[Form 4] American Healthcare REIT, Inc. Insider Trading Activity

Rhea-AI Filing Summary

American Healthcare REIT, Inc. (AHR) – Form 4 insider update

On 25 Jun 2025, director Mathieu B. Streiff received 3,042 restricted common shares at $0.00 as part of his re-election compensation. These shares will vest on 25 Jun 2026. After the grant, Streiff’s direct holdings rise to 32,377 shares, while he also indirectly controls 157,402 shares through the Streiff Family Trust, bringing total reported beneficial ownership to roughly 189,779 shares.

No sales, option exercises, or derivative positions were disclosed, and the filing reflects routine board compensation rather than a market transaction. The event marginally increases insider ownership but is unlikely to affect AHR’s share float, liquidity, or near-term valuation.

Positive

• Insider alignment increases: Streiff’s direct share ownership rose by 3,042 shares, modestly enhancing management–shareholder alignment.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine share grant; minimal valuation impact.

The 3,042-share award represents a small fraction of AHR’s outstanding equity and involves no cash proceeds. Streiff’s total holdings (~189.8k shares) indicate continued insider alignment but do not markedly shift insider ownership percentages. Without accompanying purchases or sales, the filing offers limited insight into management’s view of intrinsic value and should be considered a standard, non-market compensation event.

Corporate Governance Expert

TL;DR: Standard director compensation; governance status quo.

The one-year vesting schedule aligns the director’s incentives with shareholder interests, complying with typical REIT board remuneration practices. No Rule 10b5-1 trading plan was indicated, and the share grant maintains transparency. There are no red flags regarding control concentration or unusual perks, so governance risk remains unchanged.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Streiff Mathieu B.

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE, SUITE 300

(Street)

IRVINE CA 92612

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/25/2025		A		3,042(1)	A	$0	32,377	D
Common Stock								157,402	I	By The Streiff Family Trust UA DTD 03/26/2013(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Upon his re-election as a director to the board of directors of the Issuer on June 25, 2025, the Reporting Person was granted 3,042 shares of restricted common stock on June 25, 2025. The reported shares of restricted common stock vest on June 25, 2026.

2. The reported shares are held directly by Streiff Family Trust UA DTD 03/26/2013, and indirectly by Mathieu B. Streiff, Trustee.

Remarks:

	/s/ MATHIEU B. STREIFF	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AHR report in the latest Form 4?

Director Mathieu Streiff was granted 3,042 restricted shares on 25 Jun 2025 that vest on 25 Jun 2026.

How many AHR shares does Mathieu Streiff now own?

He directly holds 32,377 shares and indirectly controls 157,402 shares, totaling about 189,779 shares.

Was any cash paid for the new AHR shares?

No. The restricted shares were granted at $0.00 as part of board compensation.

Does the Form 4 indicate any AHR stock sales?

No sales or dispositions were reported; the filing only records an award of restricted stock.

When will the granted AHR shares vest?

The 3,042 restricted shares will vest on 25 Jun 2026.